Pituitary

1 trial
  • 1994Webster Cabergoline TrialProlactinomaIn 459 women with hyperprolactinaemic amenorrhoea, cabergoline 0.5–1.0 mg twice weekly achieved stable normoprolactinaemia, ovulation and pregnancy more often than bromocriptine.